Want to join the conversation?
$FLR narrowed its 2015 guidance for EPS from continuing operations to a range of $4.05-4.20 per diluted share, from the previous range of $4.05-4.35 per diluted share, excluding all pension settlement-related charges. For 2016, the Company is establishing its initial EPS guidance at a range of $3.50-4.00 per diluted share.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?